BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 975 filers reported holding BAXTER INTL INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,817,472 | +5.1% | 54,334 | +34.3% | 0.00% | 0.0% |
Q1 2024 | $1,729,474 | +34.0% | 40,465 | +21.2% | 0.00% | 0.0% |
Q4 2023 | $1,291,089 | -52.3% | 33,396 | -53.5% | 0.00% | -60.0% |
Q3 2023 | $2,708,600 | -0.9% | 71,770 | +19.6% | 0.01% | -9.1% |
Q2 2023 | $2,733,646 | +36.3% | 60,001 | +21.4% | 0.01% | +22.2% |
Q1 2023 | $2,005,327 | +2065.3% | 49,441 | +2621.0% | 0.01% | – |
Q4 2022 | $92,612 | -92.9% | 1,817 | -92.5% | 0.00% | -100.0% |
Q3 2022 | $1,312,000 | -81.7% | 24,355 | -78.2% | 0.01% | -83.0% |
Q2 2022 | $7,171,000 | +259.4% | 111,638 | +333.9% | 0.05% | +231.2% |
Q1 2022 | $1,995,000 | -14.2% | 25,728 | -5.0% | 0.02% | -33.3% |
Q4 2021 | $2,324,000 | -58.6% | 27,078 | -61.2% | 0.02% | -66.2% |
Q3 2021 | $5,617,000 | +45.7% | 69,833 | +45.8% | 0.07% | +29.1% |
Q2 2021 | $3,856,000 | +65.1% | 47,899 | +72.9% | 0.06% | +34.1% |
Q1 2021 | $2,336,000 | -8.8% | 27,697 | -13.3% | 0.04% | -14.6% |
Q4 2020 | $2,562,000 | -24.9% | 31,935 | -24.7% | 0.05% | -34.2% |
Q3 2020 | $3,412,000 | -18.9% | 42,426 | -13.2% | 0.07% | -14.1% |
Q2 2020 | $4,207,000 | -14.9% | 48,863 | -17.3% | 0.08% | -61.9% |
Q4 2019 | $4,941,000 | -2.8% | 59,093 | +1.7% | 0.22% | +95.6% |
Q3 2019 | $5,081,000 | +29.1% | 58,089 | +20.9% | 0.11% | +18.8% |
Q2 2019 | $3,935,000 | +12.9% | 48,042 | +12.1% | 0.10% | -1.0% |
Q1 2019 | $3,486,000 | +71.0% | 42,870 | +62.1% | 0.10% | +26.0% |
Q3 2018 | $2,039,000 | +19.9% | 26,451 | +14.9% | 0.08% | 0.0% |
Q2 2018 | $1,700,000 | +36.3% | 23,017 | +20.0% | 0.08% | +11.6% |
Q1 2018 | $1,247,000 | +13.2% | 19,173 | +12.4% | 0.07% | -10.4% |
Q4 2017 | $1,102,000 | +25.9% | 17,054 | +22.2% | 0.08% | -1.3% |
Q3 2017 | $875,000 | +14.5% | 13,952 | +10.5% | 0.08% | +2.6% |
Q2 2017 | $764,000 | +26.5% | 12,626 | +8.4% | 0.08% | +2.7% |
Q1 2017 | $604,000 | +20.8% | 11,644 | +3.2% | 0.07% | +4.2% |
Q4 2016 | $500,000 | -7.4% | 11,279 | -0.6% | 0.07% | -13.4% |
Q3 2016 | $540,000 | +4.7% | 11,347 | -0.6% | 0.08% | +1.2% |
Q2 2016 | $516,000 | +16.0% | 11,419 | +5.5% | 0.08% | -19.8% |
Q1 2016 | $445,000 | +20.6% | 10,823 | +12.0% | 0.10% | +16.1% |
Q4 2015 | $369,000 | -1.3% | 9,667 | +89.2% | 0.09% | -3.3% |
Q4 2013 | $374,000 | – | 5,109 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |